Helicobacter pylori infection and esophageal cancer risk: An updated meta-analysis

World Journal of Gastroenterology

Volumn 19, Issue 36, 2013, Pages 6098-6107

  Xie, Fa Jun ^a,b   Zhang, Yi Ping ^a   Zheng, Qiu Qing ^b   Jin, Hong Chuan ^c   Wang, Fa Liang ^c   Chen, Ming ^b   Shao, Lan ^a   Zou, De Hong ^b   Yu, Xin Min ^a   Mao, Wei Min ^b  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b Zhejiang Key Lab of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus)   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Cancer risk; Esophageal carcinoma; Helicobacter pylori; Meta analysis

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

ARTICLE; CANCER RISK; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; HELICOBACTER INFECTION; HUMAN; META ANALYSIS; NONHUMAN; PUBLISHING; SENSITIVITY ANALYSIS;

CANCER RISK; ESOPHAGEAL CARCINOMA; HELICOBACTER PYLORI; META-ANALYSIS;

ADENOCARCINOMA; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ODDS RATIO; PROGNOSIS; RISK FACTORS;

EID: 84885623275     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i36.6098     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Handa O, Naito Y, Yoshikawa T. Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Rep 2011; 16: 1-7 [PMID: 21605492 DOI: 10.1179/174329211X1296 8219310756]
3. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115 [PMID: 7743510]
4. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila) 2008; 1: 329-338 [PMID: 19138977 DOI: 10.1158/1940-6207. CAPR-08-0109]
5. Wu IC, Wu DC, Yu FJ, Wang JY, Kuo CH, Yang SF, Wang CL, Wu MT. Association between Helicobacter pylori seropositivity and digestive tract cancers. World J Gastroenterol 2009; 15: 5465-5471 [PMID: 19916178]
6. Hu HM, Kuo CH, Lee CH, Wu IC, Lee KW, Lee JM, Goan YG, Chou SH, Kao EL, Wu MT, Wu DC. Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterol 2009; 9: 37 [PMID: 19463183 DOI: 10.1186/1471-230X-9-37]
7. Murphy G, Kamangar F, Albanes D, Stanczyk FZ, Weinstein SJ, Taylor PR, Virtamo J, Abnet CC, Dawsey SM, Freedman ND. Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma. Gut 2012; 61: 1533-1537 [PMID: 22180062]
8. Venerito M, Kohrs S, Wex T, Adolf D, Kuester D, Schubert D, Peitz U, Mönkemüller K, Malfertheiner P. Helicobacter pylori infection and fundic gastric atrophy are not associated with esophageal squamous cell carcinoma: a case-control study. Eur J Gastroenterol Hepatol 2011; 23: 859-864 [PMID: 21811162 DOI: 10.1097/MEG.0b013e3283496469]
9. Khoshbaten M, Zadimani A, Bonyadi MR, Mohammadzadeh M, Gachkar L, Pourhoseingholi MA. Helicobacter pylori infection reduces the risk of esophageal squamous cell carcinoma: a case-control study in iran. Asian Pac J Cancer Prev 2011; 12: 149-151 [PMID: 21517248]
10. Cook MB, Dawsey SM, Diaw L, Blaser MJ, Perez-Perez GI, Abnet CC, Taylor PR, Albanes D, Virtamo J, Kamangar F. Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 2010; 19: 1966-1975 [PMID: 20647397 DOI: 10.1158/1055-9965.EPI-10-0270]
11. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, Zhao ZZ, Montgomery GW, Green AC, Hayward NK, Webb PM. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 2010; 139: 73-83; quiz e11-2 [PMID: 20399210 DOI: 10.1053/j.gastro.2010.04.009]
12. Früh M, Zhou W, Zhai R, Su L, Heist RS, Wain JC, Nishioka NS, Lynch TJ, Shepherd FA, Christiani DC, Liu G. Polymorphisms of inflammatory and metalloproteinase genes, Helicobacter pylori infection and the risk of oesophageal adenocarcinoma. Br J Cancer 2008; 98: 689-692 [PMID: 18253117 DOI: 10.1038/sj.bjc.6604234]
13. Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 2007; 42: 933-940 [PMID: 17613922]
14. Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, Perez-Perez GI, Abnet CC, Zhao P, Mark SD, Taylor PR, Dawsey SM. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 2007; 96: 172-176 [PMID: 17179990]
15. Wu DC, Wu IC, Lee JM, Hsu HK, Kao EL, Chou SH, Wu MT. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenterol 2005; 100: 588-593 [PMID: 15743356]
16. Ye W, Held M, Lagergren J, Engstrand L, Blot WJ, McLaughlin JK, Nyrén O. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004; 96: 388-396 [PMID: 14996860]
17. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-1739 [PMID: 1770552]
18. Peek RM, Vaezi MF, Falk GW, Goldblum JR, Perez-Perez GI, Richter JE, Blaser MJ. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer 1999; 82: 520-524 [PMID: 10404065 DOI: 10.1002/(SICI)1097-0215(19990812)82]
19. Vieth M, Masoud B, Meining A, Stolte M. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia? Digestion 2000; 62: 225-231 [PMID: 11070405]
20. Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-394 [PMID: 10685740]
21. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Chow WH. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-1201 [PMID: 12730860]
22. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815-821 [PMID: 12516104 DOI: 10.1002/ijc.10887]
23. Löfdahl HE, Lu Y, Lagergren J. Sex-specific risk factor profile in oesophageal adenocarcinoma. Br J Cancer 2008; 99: 1506-1510 [PMID: 18841152 DOI: 10.1038/sj.bjc.6604701]
24. Derakhshan MH, Malekzadeh R, Watabe H, Yazdanbod A, Fyfe V, Kazemi A, Rakhshani N, Didevar R, Sotoudeh M, Zolfeghari AA, McColl KE. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008; 57: 298-305 [PMID: 17965056]
25. Anderson LA, Murphy SJ, Johnston BT, Watson RG, Ferguson HR, Bamford KB, Ghazy A, McCarron P, McGuigan J, Reynolds JV, Comber H, Murray LJ. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008; 57: 734-739 [PMID: 18025067]
26. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 2007; 109: 668-674 [PMID: 17211862 DOI: 10.1002/cncr.22451]
27. Iijima K, Koike T, Abe Y, Inomata Y, Sekine H, Imatani A, Nakaya N, Ohara S, Shimosegawa T. Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 2007; 102: 1603-1609 [PMID: 17488251]
28. Wang Z, Tang L, Sun G, Tang Y, Xie Y, Wang S, Hu X, Gao W, Cox SB, Wang JS. Etiological study of esophageal squamous cell carcinoma in an endemic region: a population-based case control study in Huaian, China. BMC Cancer 2006; 6: 287 [PMID: 17173682]
29. de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, Corley DA, Parsonnet J. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005; 191: 761-767 [PMID: 15688293]
30. Wang KX, Wang XF, Peng JL, Cui YB, Wang J, Li CP. Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol 2003; 9: 2501-2504 [PMID: 14606084]
31. Oberg S, Peters JH, Nigro JJ, Theisen J, Hagen JA, DeMeester SR, Bremner CG, DeMeester TR. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg 1999; 134: 722-726 [PMID: 10401822]
32. Tran B, Lucas R, Kimlin M, Whiteman D, Neale R. Association between ambient ultraviolet radiation and risk of esophageal cancer. Am J Gastroenterol 2012; 107: 1803-1813 [PMID: 23032986 DOI: 10.1038/ajg.2012.329]
33. Lin SW, Fan JH, Dawsey SM, Taylor PR, Qiao YL, Abnet CC. Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort. Int J Cancer 2011; 129: 2284-2289 [PMID: 21105043 DOI: 10.1002/ijc.25789]
34. Arents NL, van Zwet AA, Thijs JC, Kooistra-Smid AM, van Slochteren KR, Degener JE, Kleibeuker JH, van Doorn LJ. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 2603-2608 [PMID: 11569682]
35. Epplein M, Zheng W, Xiang YB, Peek RM, Li H, Correa P, Gao J, Michel A, Pawlita M, Cai Q, Shu XO. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev 2012; 21: 2185-2192 [PMID: 23035179 DOI: 10.1158/1055-9965. EPI-12-0792-T]
36. Palladino-Davis AG, Mendez BM, Fisichella PM, Davis CS. Dietary habits and esophageal cancer. Dis Esophagus 2013; Epub ahead of print [PMID: 23795778 DOI: 10.1111/ dote.12097]
37. Yokokawa Y, Ohta S, Hou J, Zhang XL, Li SS, Ping YM, Nakajima T. Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water. Int J Cancer 1999; 83: 620-624 [PMID: 10521797 DOI: 10.1002/(SICI)1097-0215(19991126)83]
38. Yu X, Zhang T, Zhang H, Hu A, Hu Y, Guo W, Wang Y. Comparison of lifestyle and living environment among high risk immigrant and low risk host residents: implications for esophageal cancer etiology. Asian Pac J Cancer Prev 2010; 11: 1827-1831 [PMID: 21338241]
39. Matsuhisa T, Tsukui T. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. J Clin Biochem Nutr 2012; 50: 217-221 [PMID: 22573924 DOI: 10.3164/jcbn.11-90]
40. Umar M, Upadhyay R, Mittal B. PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis. Tumour Biol 2013; Epub ahead of print [PMID: 23797815 DOI: 10.1007/ s13277-013-0932-7]
41. Choi Y, Song S, Song Y, Lee JE. Consumption of red and processed meat and esophageal cancer risk: meta-analysis. World J Gastroenterol 2013; 19: 1020-1029 [PMID: 23467465 DOI: 10.3748/wjg.v19.i7.1020]
42. Bosetti C, La Vecchia C, Talamini R, Simonato L, Zambon P, Negri E, Trichopoulos D, Lagiou P, Bardini R, Franceschi S. Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer 2000; 87: 289-294 [PMID: 10861489 DOI: 10.1002/1097-0215(20000715)87]
43. Zhuo X, Zhang Y, Wang Y, Zhuo W, Zhu Y, Zhang X. Helicobacter pylori infection and oesophageal cancer risk: association studies via evidence-based meta-analyses. Clin Oncol (R Coll Radiol) 2008; 20: 757-762 [PMID: 18793831 DOI: 10.1016/j.clon.2008.07.005]
44. Koike T, Ohara S, Inomata Y, Abe Y, Iijima K, Shimosegawa T. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with gastroesophageal junction adenocarcinoma in Japan. Inflammopharmacology 2007; 15: 61-64 [PMID: 17450443 DOI: 10.1007/s10787-006-1549-x]
45. Sýkora J, Malán A, Záhlava J, Varvarská J, Stozǐcký F, Siala K, Schwarz J. Gastric emptying of solids in children with H. pylori-positive and H. pylori-negative non-ulcer dyspepsia. J Pediatr Gastroenterol Nutr 2004; 39: 246-252 [PMID: 15319623]